Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Cardiovascular Research
|
October 28, 2025
ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly
Haoxuan Zhong, Maieryemu Waresi, Zhiyong Qi, et al.
Nature Communications
|
October 18, 2024
TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport
Hongyi Wu, Loo Chien Wang, Belle M Sow, et al.
American Heart Journal
|
December 22, 2024
Indobufen-based dual antiplatelet therapy in patients with multivessel coronary disease undergoing drug-eluting stent implantation insight from the OPTION trial
Lili Xu, Huajie Xu, Shujing Wu, et al.
Journal of Diabetes
|
September 5, 2025
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial
Shujing Wu, Huajie Xu, Lili Xu, et al.
BMC Medicine
|
January 9, 2026
Trends in lipid-lowering therapies in acute coronary syndromes after Chinese new insurance policy: a real-world analysis
Xin Zhao, Shujing Wu, Zhen Wang, et al.
ACS Synthetic Biology
|
December 20, 2014
Quantitatively relating gene expression to light intensity via the serial connection of blue light sensor and CRISPRi
Hongyi Wu, Yushu Wang, You Wang, et al.
Scientific Reports
|
April 13, 2021
The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease
Rachel M McQuade, Lewis M Singleton, Hongyi Wu, et al.
Scientific Reports
|
October 28, 2024
Machine learning discrimination of Gleason scores below GG3 and above GG4 for HSPC patients diagnosis
Bingyu Zhu, Longguo Dai, Huijian Wang, et al.
Journal of Parkinson'S Disease
|
August 9, 2021
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease
Shanti Diwakarla, Rachel M McQuade, Remy Constable, et al.
Journal of the American Heart Association
|
December 10, 2024
Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid-Lowering Therapy
Zhendong Mei, Lili Xu, Qingxia Huang, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Cardiovascular Research
|
October 28, 2025
ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly
Haoxuan Zhong, Maieryemu Waresi, Zhiyong Qi, et al.
Nature Communications
|
October 18, 2024
TDP43 aggregation at ER-exit sites impairs ER-to-Golgi transport
Hongyi Wu, Loo Chien Wang, Belle M Sow, et al.
American Heart Journal
|
December 22, 2024
Indobufen-based dual antiplatelet therapy in patients with multivessel coronary disease undergoing drug-eluting stent implantation insight from the OPTION trial
Lili Xu, Huajie Xu, Shujing Wu, et al.
Journal of Diabetes
|
September 5, 2025
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial
Shujing Wu, Huajie Xu, Lili Xu, et al.
BMC Medicine
|
January 9, 2026
Trends in lipid-lowering therapies in acute coronary syndromes after Chinese new insurance policy: a real-world analysis
Xin Zhao, Shujing Wu, Zhen Wang, et al.
ACS Synthetic Biology
|
December 20, 2014
Quantitatively relating gene expression to light intensity via the serial connection of blue light sensor and CRISPRi
Hongyi Wu, Yushu Wang, You Wang, et al.
Scientific Reports
|
April 13, 2021
The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease
Rachel M McQuade, Lewis M Singleton, Hongyi Wu, et al.
Scientific Reports
|
October 28, 2024
Machine learning discrimination of Gleason scores below GG3 and above GG4 for HSPC patients diagnosis
Bingyu Zhu, Longguo Dai, Huijian Wang, et al.
Journal of Parkinson'S Disease
|
August 9, 2021
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's Disease
Shanti Diwakarla, Rachel M McQuade, Remy Constable, et al.
Journal of the American Heart Association
|
December 10, 2024
Metabonomic Biomarkers of Plaque Burden and Instability in Patients With Coronary Atherosclerotic Disease After Moderate Lipid-Lowering Therapy
Zhendong Mei, Lili Xu, Qingxia Huang, et al.
Page
of 9